Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Solid Tumor Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00207103
What this trial is testing

MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
TumorsNeoplasm Metastasis
Bristol-Myers Squibb 68
Early research (Phase 1)Looking for participantsNCT06640413
What this trial is testing

Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors

Who this might be right for
FAP
Philogen S.p.A. 56
Testing effectiveness (Phase 2)Ended earlyNCT05109442
What this trial is testing

Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers

Who this might be right for
Advanced Solid Tumor
Affimed GmbH 112
Testing effectiveness (Phase 2)Study completedNCT00020046
What this trial is testing

Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Looking for participantsNCT07108114
What this trial is testing

SLV-324 Treatment of Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Solve Therapeutics 70
Early research (Phase 1)Looking for participantsNCT06241898
What this trial is testing

A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Bliss Biopharmaceutical (Hangzhou) Co., Ltd 300
Testing effectiveness (Phase 2)Study completedNCT01267084
What this trial is testing

Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

Who this might be right for
Neoplasm Metastases
Janssen Research & Development, LLC 12
Testing effectiveness (Phase 2)Study completedNCT00389584
What this trial is testing

Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCognitive/Functional EffectsLong-term Effects Secondary to Cancer Therapy in Adults+4 more
University of California, Davis 30
Not applicableLooking for participantsNCT01050504
What this trial is testing

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Who this might be right for
Localized Renal Pelvis and Ureter Urothelial CarcinomaMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Bone+8 more
University of Washington 1,500
Early research (Phase 1)UnknownNCT03415100
What this trial is testing

Pilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid Tumours

Who this might be right for
Solid Tumours
The Third Affiliated Hospital of Guangzhou Medical University 30
Early research (Phase 1)Study completedNCT00003711
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
San Antonio Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT01804634
What this trial is testing

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Who this might be right for
Refractory and/or Relapsed Metastatic Solid Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Early research (Phase 1)Study completedNCT00390052
What this trial is testing

3-AP in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT01562899
What this trial is testing

MEK162 and AMG 479 in Patients With Selected Solid Tumors

Who this might be right for
Metastatic Pancreatic AdenocarcinomaBRAF Mutated Melanoma
Pfizer 77
Early research (Phase 1)Looking for participantsNCT07247110
What this trial is testing

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 250
Testing effectiveness (Phase 2)Ended earlyNCT00001880
What this trial is testing

Stem Cell Transplantation for Metastatic Solid Tumors

Who this might be right for
Neoplasm Metastasis
National Heart, Lung, and Blood Institute (NHLBI) 42
Early research (Phase 1)Study completedNCT00005839
What this trial is testing

Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center
Early research (Phase 1)Study completedNCT01357330
What this trial is testing

Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Sanofi 18
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)Study completedNCT03890731
What this trial is testing

A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed

Who this might be right for
Solid Cancer
Bayer 6
Next Page